<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27849305</article-id><article-id pub-id-type="pmc">5094417</article-id><article-id pub-id-type="doi">10.5935/1678-9741.20160070</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Treatment of Chronic Atrial Fibrillation During Surgery for Rheumatic Mitral
Valve Disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gon&#x000e7;alves</surname><given-names>Flavio Donizete</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>Leite</surname><given-names>Valdir Gon&#x000e7;alves</given-names><suffix>Junior</suffix></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Leite</surname><given-names>Vanusa Gon&#x000e7;alves</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Maia</surname><given-names>Marcelo Alves</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Gomes</surname><given-names>Otoni Moreira</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Lima</surname><given-names>Melchior Luiz</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Osterne</surname><given-names>Evandro C&#x000e9;sar Vidal</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Kall&#x000e1;s</surname><given-names>Elias</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib></contrib-group><aff id="aff1"><label>1</label> Hospital Aroldo Tourinho, Montes Claros, MG, Brazil. </aff><aff id="aff2"><label>2</label> Funda&#x000e7;&#x000e3;o Cardiovascular S&#x000e3;o Francisco de Assis -
ServCor- Belo Horizonte, MG, Brazil. </aff><author-notes><corresp id="c1"><bold>Correspondence Address:</bold> Flavio Donizete Gon&#x000e7;alves,
Hospital Aroldo Tourinho, Rua Carlos Leite, 258 &#x02013; Morrinhos, Montes Claros, MG, Brazil &#x02013;
Zip code: 39400-451, E-mail: <email>flaviodonizetegoncalves@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Jul-Sep</season><year>2016</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Jul-Sep</season><year>2016</year></pub-date><volume>31</volume><issue>4</issue><fpage>318</fpage><lpage>324</lpage><history><date date-type="received"><day>21</day><month>7</month><year>2015</year></date><date date-type="accepted"><day>11</day><month>7</month><year>2016</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Introduction</title><p>The result of surgical ablation of atrial fibrillation remains controversial, although
prospective and randomized studies have shown significant differences in the return to
sinus rhythm in patients treated with ablation <italic>versus</italic> control group.
Surgery of the Labyrinth, proposed by Cox and colleagues, is complex and increases the
morbidity rate. Therefore, studies are needed to confirm the impact on clinical outcomes
and quality of life of these patients.</p></sec><sec><title>Objective</title><p>To analyze the results obtained in the treatment of atrial fibrillation by surgical
approach, by Gomes procedure, for mitral valve surgery in patients with rheumatic heart
disease associated with chronic atrial fibrillation.</p></sec><sec><title>Methods</title><p>We studied 20 patients with mitral valve dysfunction of rheumatic etiology, evolving
with chronic atrial fibrillation, submitted to surgical treatment of valvular
dysfunction and atrial fibrillation by Gomes procedure.</p></sec><sec><title>Results</title><p>The mean duration of infusion ranged from 65.8&#x000b1;11.22 and aortic clamping of
40.8&#x000b1;7.87 minutes. Of 20 patients operated, 19 (95%) patients were discharged
with normal atrial heart rhythm. One (5%) patient required permanent endocardial pacing.
In the postoperative follow-up of six months, 18 (90%) patients continued with regular
atrial rhythm, one (5%) patient returned to atrial fibrillation and one (5%) patient
continued to require endocardial pacemaker to maintain regular rhythm.</p></sec><sec><title>Conclusion</title><p>Gomes procedure associated with surgical correction of mitral dysfunction simplified
the surgical ablation of atrial fibrillation in patients with rheumatic mitral valve
disease and persistent atrial fibrillation. The results showed that it is a safe and
effective procedure.</p></sec></abstract><kwd-group><kwd>Rheumatic Heart Disease</kwd><kwd>Heart Valves</kwd><kwd>Mitral Valve</kwd><kwd>Atrial Fibrillation</kwd></kwd-group></article-meta></front><body><table-wrap id="t4" orientation="portrait" position="anchor"><table frame="hsides" rules="groups" style="background-color:#e6e7e8"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Abbreviations, acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">AFFIRM</td><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;=Atrial Fibrillation Follow-up
Investigation of Rhythm Management</td></tr><tr><td align="left" rowspan="1" colspan="1">CPB</td><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;=Cardiopulmonary bypass</td></tr><tr><td align="left" rowspan="1" colspan="1">ICU</td><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;=Intensive care unit</td></tr><tr><td align="left" rowspan="1" colspan="1">INR</td><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;=International normalized ratio</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Due to the lack of knowledge of electrophysiological mechanisms of atrial fibrillation, for
a long time, reduction of ventricular rate was the only existing treatment for the reduction
of symptoms. Pharmacological treatment of this disease relies on the use of antiarrhythmic
drugs. In patients with risk factors for thromboembolic events, anticoagulants are
associated. However, in medium and long-term, drug therapy is unable to prevent the
recurrence of atrial fibrillation outbreaks in 50% of patients, which leads to significant
loss of life quality<sup>[<xref rid="B1" ref-type="bibr">1</xref>]</sup>.</p><p>Several studies attested such claims, particularly the multicenter study "Atrial
Fibrillation Follow-up Investigation of Rhythm Management" (AFFIRM)<sup>[<xref rid="B2" ref-type="bibr">2</xref>]</sup>, which reported that the antiarrhythmic drug
therapy for maintenance of sinus rhythm was not beneficial when compared to the ventricular
rate control associated with anticoagulation in relation to mortality and ischemic
stroke.</p><p>Pharmacological clinical treatments of atrial fibrillation, in addition to not correcting
it and being costly, has significant morbidity and mortality, justifying the urgent need for
invasive alternative treatment, whether surgical or percutaneous<sup>[<xref rid="B3" ref-type="bibr">3</xref>]</sup>.</p><p>The surgical alternative to atrial fibrillation treatment became a reality from studies of
Haissaguerre et al.<sup>[<xref rid="B4" ref-type="bibr">4</xref>]</sup>, which highlighted
the key role of the pulmonary veins in the pathophysiology of atrial fibrillation
episodes.</p><p>In Brazil, rheumatic heart disease still has a high prevalence. Its structural sequelae
represent one of the main causes of heart valve surgery. In this context, atrial
fibrillation of rheumatic nature, obviously, remains a major medical and surgical
problem<sup>[<xref rid="B5" ref-type="bibr">5</xref>]</sup>.</p><p>In patients with mitral valve disease and atrial fibrillation, surgical correction of
valvular dysfunction does not result generally in solution for arrhythmia, because
recurrence rates are high, reaching up to 80% in six months<sup>[<xref rid="B6" ref-type="bibr">6</xref>]</sup>.</p><p>Coumel et al.<sup>[<xref rid="B7" ref-type="bibr">7</xref>]</sup>, performed the first
surgery for the treatment of ectopic foci of arrhythmia located in the left atrial, leading
to the subsequent development of left atrial isolation techniques in the treatment of atrial
fibrillation.</p><p>The evolution of atrial fibrillation surgery included the development of less invasive
surgical techniques, by replacing the section lines and atrial sutures by the use of energy
sources in the atrial myocardium. The goal was to create transmural lesions to block the
macro reentry circuits. The main energy sources currently employed are cryothermia,
radiofrequency, microwave, ultrasound and laser beams<sup>[<xref rid="B5" ref-type="bibr">5</xref>]</sup>.</p><p>The results of surgical ablation of atrial fibrillation remains controversial, although
prospective and randomized studies have shown significant differences in the return to sinus
rhythm in patients treated with ablation <italic>versus</italic> control group. However,
further studies are needed to confirm the impact on clinical outcomes and quality of life of
these patients<sup>[<xref rid="B8" ref-type="bibr">8</xref>]</sup>.</p><p>The innovative highlight was the publication of Gomes &#x00026; Gomes<sup>[<xref rid="B9" ref-type="bibr">9</xref>]</sup>, who described pioneering surgical procedure of
simultaneous correction of mitral valve disease associated with atrial fibrillation.</p><p>This study aims to present the results of Gomes procedure in randomly consecutive patients
with rheumatic mitral valve disease and chronic atrial fibrillation.</p></sec><sec sec-type="methods"><title>METHODS</title><p>From June 2006 to March 2013, 20 patients, 15 (75%) female gender and 5 (25%) male, with
ages between 20-65 years (mean 44.25&#x000b1;13.9) carriers of rheumatic mitral valve disease
and chronic atrial fibrillation (lasting at least 1 year) were operated at the
Cardiovascular Surgery Service of the Hospital Aroldo Tourinho, Montes Claros - Minas
Gerais, Brazil (<xref ref-type="table" rid="t1">Table 1</xref>). The study was approved by
the Research Ethics Committee of the Hospital Aroldo Tourinho.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Demographic data of patients.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="33%" span="1"/><col width="33%" span="1"/><col width="33%" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Patient</th><th align="center" rowspan="1" colspan="1"><xref ref-type="table-fn" rid="TFN1">*</xref>Age (years)</th><th align="center" rowspan="1" colspan="1">Gender</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">57</td><td align="center" rowspan="1" colspan="1">M</td></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">45</td><td align="center" rowspan="1" colspan="1">F</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">53</td><td align="center" rowspan="1" colspan="1">F</td></tr><tr><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">65</td><td align="center" rowspan="1" colspan="1">M</td></tr><tr><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">F</td></tr><tr><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">42</td><td align="center" rowspan="1" colspan="1">M</td></tr><tr><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">38</td><td align="center" rowspan="1" colspan="1">M</td></tr><tr><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">51</td><td align="center" rowspan="1" colspan="1">F</td></tr><tr><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">F</td></tr><tr><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">F</td></tr><tr><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">59</td><td align="center" rowspan="1" colspan="1">F</td></tr><tr><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">52</td><td align="center" rowspan="1" colspan="1">F</td></tr><tr><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">F</td></tr><tr><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">F</td></tr><tr><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">37</td><td align="center" rowspan="1" colspan="1">F</td></tr><tr><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">F</td></tr><tr><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">F</td></tr><tr><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">65</td><td align="center" rowspan="1" colspan="1">F</td></tr><tr><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">44</td><td align="center" rowspan="1" colspan="1">F</td></tr><tr><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">61</td><td align="center" rowspan="1" colspan="1">M</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>*</label><p>Mean 44.25&#x000b1;13.78 F=female; M=male</p></fn></table-wrap-foot></table-wrap><p>The symptoms related to mitral valve disease were the reason to the surgical indication in
all patients. None of the patients was operated on an emergency basis. All patients
underwent preoperative echocardiography to study heart valves and analysis of intra cavity
thrombi in addition to evaluate parameters such as left atrium diameter, left ventricular
ejection fraction, valve area and right chambers pressure.</p><p>Cardiac catheterizations were performed in patients aged greater than or equal to 40 years,
not revealing obstructions in the coronary arteries in any of them.</p><p>Inclusion criteria were patients with rheumatic mitral valve disease and chronic atrial
fibrillation.</p><p>The exclusion criterion was the need for other associated surgical procedures.</p><p>The following data from records collected on the day of surgery were considered to study:
cardiopulmonary bypass time, aortic clamping time, sinus rhythm correction and postoperative
bleeding.</p><p>The cardiac rhythm was evaluated in four different times: after release of the aortic
clamp, in the intensive care unit (ICU), at hospital discharge and at the end of the
postoperative follow-up.</p><p>All patients received amiodarone 200 mg/day and sodium warfarin 5 mg/day adjusted as
international normalized ratio (INR) of prothrombin activity for 3 months.</p><p>The surgical technique included the use of normothermic cardiopulmonary bypass (36-37.5&#x000ba;C)
with total venous drainage through cannulas inserted in the upper and lower vena cava,
through areas bounded by sutures in bags in the right atrium. The suture of the tube from
the superior vena cava was placed 5 mm from the base of the right atrium appendage.</p><p>The cannula for systemic arterial perfusion was inserted into the distal portion of the
ascending aorta. The cannula for coronary arterial cardioplegic perfusion was inserted into
the proximal portion of the aorta. Myocardial protection was achieved with blood coronary
perfusion anterograde hyperkalemic (25 mEq/l), hypothermic (4&#x000b0;C), with perfusion pressure of
60-90 mmHg and intermittent. It was repeated every 20 to 25 minutes.</p><p>To access the mitral valve, atrial ostia of the pulmonary veins and the left atrial
appendage, as well to section the atrial septal and right atrial conduction areas, a single
oblique incision was used. This incision was started 5 mm above the right atrioventricular
groove and extended up to 15 mm in the anterior contour of the right superior pulmonary vein
with section of the atrial septum up to 10 mm above the annulus of the tricuspid valve
(<xref ref-type="fig" rid="f1">Figure 1</xref>).</p><p><fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Purse string suture at the base of the right atrium appendage and biatrial incision
to section the atrial septum.</p></caption><graphic xlink:href="rbccv-31-04-0318-g01"/></fig>
</p><p>Thrombi in the left atrium, present in 20% of cases, were removed.</p><p>Compartmentalization of the left atrium was performed with the use of electrocautery,
isolating the pulmonary vein ostia (<xref ref-type="fig" rid="f2">Figure 2</xref>).</p><p><fig id="f2" orientation="portrait" position="float"><label>Fig 2</label><caption><p>Left atrium open revealing line of cauterization of the pulmonary vein ostia.</p></caption><graphic xlink:href="rbccv-31-04-0318-g02"/></fig>
</p><p>The left atrial appendage was excluded by continuous suture from its base in the
communication ostium with the left atrium.</p><p>The circuits of anomalous focus of cardiac stimulation, in the superior and inferior vena
cava were interrupted by longitudinal sutures, each one measuring 1 cm in length (<xref ref-type="fig" rid="f3">Figure 3</xref>).</p><p><fig id="f3" orientation="portrait" position="float"><label>Fig.3</label><caption><p>Longitudinal suture in the anterior contours of the superior vena cava (arrow).</p></caption><graphic xlink:href="rbccv-31-04-0318-g03"/></fig>
</p><p>The reconstruction of the atrial septum, the right superior pulmonary vein and the right
atrial wall, continuous sutures were used in single plane with 3-0 polypropylene thread. The
right atrium auricle was excluded by simply closure of purse string suture after removal of
the superior vena cava cannula.</p></sec><sec sec-type="results"><title>RESULTS</title><p>In 18 patients, mitral valve replacement was performed by pericardial bioprosthesis, 10
units from the Labcor<sup>&#x000ae;</sup>, 6 units from Braile<sup>&#x000ae;</sup> and 2 units
from Saint Jude<sup>&#x000ae;</sup> In 2 patients, the mitral valve was preserved,
commissurotomy being held in one patient and valvuloplasty with mitral repair ring
Carpentier type (Labcor<sup>&#x000ae;</sup>) in another patient.</p><p>The left atrial size ranged from 4.5 to 6.0 cm and 5 patients had thrombi in the atrium and
left atrial appendage. The extracorporeal perfusion time ranged 43-88 minutes averaging 65.8
minutes, and the aortic clamping time ranged 22-50 minutes with an average of 40.8
minutes.</p><p>There was no mortality in patients studied in the six months follow-up. In one (5%) patient
was necessary dual-chamber pacemaker implantation because of symptomatic sinus bradycardia,
and this patient already had atrial fibrillation with pauses longer than 2 seconds before
the operation.</p><p>No patient had hemorrhagic or thromboembolic complication during the study follow-up period
(<xref ref-type="table" rid="t2">Table 2</xref>).</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Postoperative bleeding and blood transfusion.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/></colgroup><thead><tr><th align="center" rowspan="2" colspan="1">Patient</th><th align="center" rowspan="2" colspan="1">Blood transfusion</th><th align="center" colspan="2" rowspan="1">Bleeding (ml)</th></tr><tr><th align="center" rowspan="1" colspan="1">1<sup>st</sup>hour</th><th align="center" rowspan="1" colspan="1">24<sup>rd</sup>hour</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">280</td><td align="center" rowspan="1" colspan="1">550</td></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">400</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">125</td><td align="center" rowspan="1" colspan="1">300</td></tr><tr><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">150</td></tr><tr><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">1000</td></tr><tr><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">150</td></tr><tr><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">300</td></tr><tr><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">200</td></tr><tr><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">70</td></tr><tr><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">200</td><td align="center" rowspan="1" colspan="1">600</td></tr><tr><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">125</td></tr><tr><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">75</td><td align="center" rowspan="1" colspan="1">150</td></tr><tr><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">140</td></tr><tr><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">40</td><td align="center" rowspan="1" colspan="1">300</td></tr><tr><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">180</td><td align="center" rowspan="1" colspan="1">400</td></tr><tr><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">150</td></tr><tr><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">300</td></tr><tr><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">450</td></tr><tr><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">125</td><td align="center" rowspan="1" colspan="1">550</td></tr><tr><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">75</td><td align="center" rowspan="1" colspan="1">350</td></tr></tbody></table></table-wrap><p>In all patients, we obtained regular atrial cardiac rhythm, with hemodynamic stabilization
at the end of cardiopulmonary bypass. Thus, 19 patients were released from ICU and later
discharged with sustained regular atrial heart rhythm.</p><p>One (5%) patient required endocardial dual-chamber pacemaker implantation because of
symptomatic sinus bradycardia (<xref ref-type="table" rid="t3">Table 3</xref>).</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Perioperative results.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Patient</th><th align="center" rowspan="1" colspan="1">Cardiopulmonary bypass time (min)</th><th align="center" rowspan="1" colspan="1">Aortic clamping time (min)</th><th align="center" rowspan="1" colspan="1">Procedure</th><th align="center" rowspan="1" colspan="1">Diameter (mm)</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">69</td><td align="center" rowspan="1" colspan="1">45</td><td align="center" rowspan="1" colspan="1">Valve replacement</td><td align="center" rowspan="1" colspan="1">29</td></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">61</td><td align="center" rowspan="1" colspan="1">43</td><td align="center" rowspan="1" colspan="1">Valve replacement</td><td align="center" rowspan="1" colspan="1">31</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">37</td><td align="center" rowspan="1" colspan="1">Valve replacement</td><td align="center" rowspan="1" colspan="1">29</td></tr><tr><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">70</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">Valve replacement</td><td align="center" rowspan="1" colspan="1">33</td></tr><tr><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">66</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">Valve replacement</td><td align="center" rowspan="1" colspan="1">31</td></tr><tr><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">57</td><td align="center" rowspan="1" colspan="1">38</td><td align="center" rowspan="1" colspan="1">Valve replacement</td><td align="center" rowspan="1" colspan="1">31</td></tr><tr><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">75</td><td align="center" rowspan="1" colspan="1">41</td><td align="center" rowspan="1" colspan="1">Valve replacement</td><td align="center" rowspan="1" colspan="1">29</td></tr><tr><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">66</td><td align="center" rowspan="1" colspan="1">55</td><td align="center" rowspan="1" colspan="1">Valve replacement</td><td align="center" rowspan="1" colspan="1">29</td></tr><tr><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">77</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">Valve replacement</td><td align="center" rowspan="1" colspan="1">29</td></tr><tr><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">88</td><td align="center" rowspan="1" colspan="1">44</td><td align="center" rowspan="1" colspan="1">Valve replacement</td><td align="center" rowspan="1" colspan="1">27</td></tr><tr><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">79</td><td align="center" rowspan="1" colspan="1">51</td><td align="center" rowspan="1" colspan="1">Valve replacement</td><td align="center" rowspan="1" colspan="1">29</td></tr><tr><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">69</td><td align="center" rowspan="1" colspan="1">40</td><td align="center" rowspan="1" colspan="1">Valve replacement</td><td align="center" rowspan="1" colspan="1">29</td></tr><tr><td align="center" rowspan="1" colspan="1">13*</td><td align="center" rowspan="1" colspan="1">70</td><td align="center" rowspan="1" colspan="1">46</td><td align="center" rowspan="1" colspan="1">Valve replacement</td><td align="center" rowspan="1" colspan="1">27</td></tr><tr><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">57</td><td align="center" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1">Valve replacement</td><td align="center" rowspan="1" colspan="1">29</td></tr><tr><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">47</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">Commissurotomy</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">43</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">Valve replacement</td><td align="center" rowspan="1" colspan="1">27</td></tr><tr><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">59</td><td align="center" rowspan="1" colspan="1">42</td><td align="center" rowspan="1" colspan="1">Valve replacement</td><td align="center" rowspan="1" colspan="1">31</td></tr><tr><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">75</td><td align="center" rowspan="1" colspan="1">40</td><td align="center" rowspan="1" colspan="1">Valve replacement</td><td align="center" rowspan="1" colspan="1">29</td></tr><tr><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">70</td><td align="center" rowspan="1" colspan="1">40</td><td align="center" rowspan="1" colspan="1">Valve replacement</td><td align="center" rowspan="1" colspan="1">29</td></tr><tr><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">69</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">Annuloplasty</td><td align="center" rowspan="1" colspan="1">30</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><label>*</label><p>Pacemaker</p></fn></table-wrap-foot></table-wrap><p>All patients were discharged in stable clinical conditions, with 19 patients in regular
rhythm with presence of the P wave and one patient in dual chamber pacemaker rhythm.</p><p>In the postoperative six months follow-up, 18 (90%) patients continued with regular atrial
rhythm, one (5%) patient returned to atrial fibrillation and one patient presented with
sinus bradycardia, requiring endocardial pacemaker implantation (5%).</p><p>During hospitalization and 12 weeks after surgery, 19 patients received amiodarone 200 mg
daily and Warfarin sodium as INR.</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Atrial fibrillation is a supraventricular arrhythmia of higher clinical interest, not only
for its high incidence, but also by the possibility of developing severe cardiovascular
disorders, such as stroke or heart failure<sup>[<xref rid="B10" ref-type="bibr">10</xref>]</sup>.</p><p>Its prevalence may vary from 0.15% to 1%, increasing gradually with age. In individuals
older than 62 the prevalence can reach 5% to 9%<sup>[<xref rid="B11" ref-type="bibr">11</xref>]</sup>. With the growing interest in understanding the pathophysiology
responsible for the occurrence of this arrhythmia, operative techniques have been developed
in order to increase the effectiveness of this operation and reduce the possibility of
treatment failure, which can reach 20% of patients undergoing operative procedures for
treatment of arrhythmia in association with mitral valve management<sup>[<xref rid="B12" ref-type="bibr">12</xref>]</sup>.</p><p>Developed over 10 years, the Maze operation is still considered the reference method for
the surgical treatment of atrial fibrillation. However, the routine use of this surgery is
limited to a few centers, given its complexity.</p><p>Several studies have shown that in controlling atrial fibrillation, the mere creation of
lines by cutting and suturing or a radiofrequency ablation, contouring or uniting the ostia
of the pulmonary veins determines clinical results similar to those obtained by the Maze
procedure<sup>[<xref rid="B6" ref-type="bibr">6</xref>]</sup>.</p><p>Different surgical techniques have been proposed with the common point of targeting
interventions to the posterior wall of the left atrium, more specifically for the region of
the pulmonary veins. Jatene et al.<sup>[<xref rid="B13" ref-type="bibr">13</xref>]</sup>
performed the Cox surgery for treatment of atrial fibrillation in 45 patients with rheumatic
mitral valve disease due to its usual occurrence in our country, but in this study instead
of Cox surgery, we used the technique reported by Gomes &#x00026; Gomes<sup>[<xref rid="B9" ref-type="bibr">9</xref>]</sup> also to treat rheumatic mitral valve disease
associated with atrial fibrillation.</p><p>In Brazil, Jazbik et al.<sup>[<xref rid="B14" ref-type="bibr">14</xref>]</sup>, have
proposed different surgical techniques for the management of atrial fibrillation, and its
common point would be the left atrium reduction by excision of atrial tissue bands.
Vasconcelos et al.<sup>[<xref rid="B15" ref-type="bibr">15</xref>]</sup> performed a study
to evaluate the effectiveness of surgical isolation of the left atrial posterior wall
involving the ostia of the pulmonary veins for the treatment of atrial fibrillation in
patients with rheumatic mitral valve disease.</p><p>Gomes &#x00026; Gomes<sup>[<xref rid="B9" ref-type="bibr">9</xref>]</sup> technique replaces
the resection of the right and left atrial appendages. It uses a purse string suture, in the
introduction of the cannula in the superior vena cava in the right atrium and by the closing
of the ostium of the left atrial appendage by intra-atrial suture respectively; and
facilitates to a broad internal exposure of the left atrium by the single atrial
incision.</p><p>From the electrophysiological point of view, a single incision in the right atrium excludes
one of the stimuli of reentry circuits in the atrial wall and also the septal channels. The
circuits near the ostia of the superior and inferior vena cava veins were considered by
Frame et al.<sup>[<xref rid="B16" ref-type="bibr">16</xref>]</sup> as capable of generating
tachyarrhythmias. Interruption can be performed easily by applying a simple suture of 1 cm
in length in the anterior border of the vena cava.</p><p>Brick et al.<sup>[<xref rid="B5" ref-type="bibr">5</xref>]</sup> report's approach carried
out along the lines described by Haissaguerre et al.<sup>[<xref rid="B4" ref-type="bibr">4</xref>]</sup>, done with the application of radiofrequency so it decreased the
duration of CPB, together with all its benefits.</p><p>Cox operation, carried out in Brazil by Jatene et al.<sup>[<xref rid="B13" ref-type="bibr">13</xref>]</sup>, showed excellent results in the reversal of atrial fibrillation,
particularly in heart valve disease to sinus rhythm. However, as described by Cox et
al.<sup>[<xref rid="B17" ref-type="bibr">17</xref>]</sup>, which highlighted the
prolonged times of CPB, these authors cite as limiting the long time of operation when
performed by less experienced professionals is perhaps a limiting factor for the spread of
the technique.</p><p>The CPB time and smaller aortic clamping are very important, because both are associated
with the risk of complications in surgery. In the present study the CPB time ranged from
43-88 minutes (65.8&#x000b1;11.2) and the aortic clamping time 22-50 minutes
(40.8&#x000b1;7.9); shorter than that obtained in the Cox surgery even in referral
centers.</p><p>Cox et al.<sup>[<xref rid="B17" ref-type="bibr">17</xref>]</sup> compartmentalized the
right and left atria through the section of the walls and suturing in lines for the purpose
of disrupting micro entries; while Gomes J&#x000fa;nior et al.<sup>[<xref rid="B18" ref-type="bibr">18</xref>]</sup>, used the left atrial longitudinal incision. In this study,
we used the single oblique atrial incision in the right atrium and the atrial septum
extending to the right superior pulmonary vein, causing section of interatrial and septal
pathways.</p><p>In the Vasconcelos et al.<sup>[<xref rid="B15" ref-type="bibr">15</xref>]</sup> study, the
inclusion of a control group permitted the establishing of the isolation of the posterior
wall of the left atrium, encompassing the ostia of the pulmonary veins, used concomitantly
with the valvular surgical treatment in patients with chronic rheumatic heart disease. It is
a safe and effective procedure in the treatment of atrial fibrillation, promoting a
reduction in the incidence of recurrence of arrhythmia, both in the perioperative phase in
late stage.</p><p>Saad &#x00026; Camanho<sup>[<xref rid="B19" ref-type="bibr">19</xref>]</sup> report that the
selection of patients for radiofrequency ablation procedure with persistent or permanent
forms of atrial fibrillation follows the same reasoning, but the decision should be
individualized according to the duration of atrial fibrillation and the size of theleft
atrium, an important predictor of recurrence. Even with extensive applications of
radiofrequency, the rate of recurrence and the need for new procedures are higher in this
group, reaching 40% of cases.</p><p>Kosakai et al.<sup>[<xref rid="B20" ref-type="bibr">20</xref>]</sup>, in a series of 62
mitral valve disease patients, succeeded in controlling atrial fibrillation in 84% of them,
expanding more recently the series and keeping the same results. These authors attribute the
increased size of the left atrium the failure registered in about 10% of the patients, who
did not obtain control of atrial fibrillation. In Jatene et al.<sup>[<xref rid="B13" ref-type="bibr">13</xref>]</sup>, experience where the average size of the left atrium was 5.5
cm, it was possible to control atrial fibrillation in 90% of cases, including people with
different valve disease, including the valve reoperation. In 2 patients who remained in a
long-term atrial fibrillation, the left atrium measured about 6.0 cm, which was perhaps one
of the main factors for the failure of the operation. The left atrial size ranged from 4.5
to 6.0 cm and did not interfere in the atrial fibrillation correction results in patients in
this study.</p><p>Gomes &#x00026; Gomes<sup>[<xref rid="B9" ref-type="bibr">9</xref>]</sup> obtained regular
atrial rhythm with hemodynamic stabilization at the end of CPB in all patients.</p><p>The results observed by Jatene et al.<sup>[<xref rid="B13" ref-type="bibr">13</xref>]</sup>, using the Cox technique showed cardioversion of atrial fibrillation to
regular rhythm in all cases after CPB, with maintenance of the results in a short and long
term follow-up by 95%.</p><p>Lins et al.<sup>[<xref rid="B21" ref-type="bibr">21</xref>]</sup> report that the
cardioversion of atrial fibrillation to sinus rhythm in the immediate postoperative period
was 20 (90.9%) from 22 patients in the group receiving ablation <italic>versus</italic> 3
(13.6%) of the 22 patients group which were not submitted to ablation.</p><p>In the Brick et al.<sup>[<xref rid="B5" ref-type="bibr">5</xref>]</sup> series of cases
study was observed reversal from atrial fibrillation rhythm to sinus rhythm in 24 (88.8%) of
the 27 patients in the immediate postoperative period and was 22 (81.4%) at hospital
discharge.</p><p>In this study, there was a reversal to sinus rhythm in all patients at the end of CPB.
However, one patient with symptomatic sinus bradycardia required a definitive endocardial
pacemaker implantation. In cases of mitral valve disease associated with atrial
fibrillation, the use of Gomes &#x00026; Gomes<sup>[<xref rid="B9" ref-type="bibr">9</xref>]</sup> technique in association with treatment of valve disease, there can be
observed significant clinical improvement of patients in the late postoperative period. This
situation was also observed in reports of Kosakai et al.<sup>[<xref rid="B20" ref-type="bibr">20</xref>]</sup>.</p><p>Calkins et al.<sup>[<xref rid="B22" ref-type="bibr">22</xref>]</sup>, observed reversion to
sinus rhythm in 28% of left atrium after intervention on mitral valve showing correlation of
the diameter of the left atrium (left atrium &#x0003e; 52 mm) with the maintenance of atrium
fibrillation despite the effective treatment of valve disease mitral.</p><p>In this study, 19 patients were discharged from hospital in regular sinus rhythm and 1
patient required endocardial pacing due to sinus bradycardia.</p><p>Jatene et al.<sup>[<xref rid="B13" ref-type="bibr">13</xref>]</sup>, found that low cardiac
output was a complication observed in 5 patients. Kosakai et al.<sup>[<xref rid="B20" ref-type="bibr">20</xref>]</sup> used the intra-aortic balloon pump in 4 patients with low
cardiac output. Sandoval et al.<sup>[<xref rid="B23" ref-type="bibr">23</xref>]</sup>,
observed one case of a low cardiac output followed by death.</p><p>Kosakai et al.<sup>[<xref rid="B20" ref-type="bibr">20</xref>]</sup> found an incidence of
reoperation around 8% in the group of patients who underwent surgical treatment of atrial
fibrillation, all with mitral valve disease.</p><p>Despite being a surgical procedure that requires careful surgical technique with bleeding
potential this was not a complication observed in this study.</p><p>The embolic phenomena in the preoperative period of patients with mitral valve disease
although more often associated with atrial fibrillation, also present a significant
incidence in patients with sinus rhythm.</p><p>Boersma et al.<sup>[<xref rid="B24" ref-type="bibr">24</xref>]</sup> reported a lower
incidence of stroke and thromboembolism in surgical ablation when compared with catheter
ablation in follow-up of 12 months. These findings are due to the fact that in the surgical
procedure the thrombus in the left atrium can be easily removed during surgery.</p><p>In this study, although the occurrence of thrombi in the left atrial appendage has happened
in 20% of patients, there were no cases of stroke or embolism during the follow-up period,
probably due to direct removal of thrombus in the perioperative term.</p><p>Canale et al.<sup>[<xref rid="B25" ref-type="bibr">25</xref>]</sup> report that surgical
mortality of 13% reflects the gravity and the late stage of the disease in these patients
which are referred for surgery and considering the presence of atrial fibrillation
demonstrates an advanced mitral disease.</p><p>Gomes &#x00026; Gomes<sup>[<xref rid="B9" ref-type="bibr">9</xref>]</sup>, as well as Stulak et
al.<sup>[<xref rid="B10" ref-type="bibr">10</xref>]</sup>, report that there was no
mortality in the patients undergoing surgery.</p><p>Stulak et al.<sup>[<xref rid="B10" ref-type="bibr">10</xref>]</sup>, in 2006, reported that
three patients in the studied group (37 patients) required a permanent pacemaker due to
sinus node disease.</p><p>In this study, along the 6 months follow-up there was no mortality. One (5%) patient
required permanent pacemaker implantation, and this patient already had pauses
preoperatively with pacemaker indication prior to correction of the atrial fibrillation.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>The consistent results of this study demonstrate that Gomes technique is a safe and
effective therapeutic procedure for the treatment of chronic atrial fibrillation in surgery
of patients with rheumatic mitral valve disease.</p><table-wrap id="t5" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors&#x02019; roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">FDG</td><td align="left" rowspan="1" colspan="1">Conception and design study; realization of operations and/or trials;
manuscript writing or critical review of its content; final manuscript approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">VGLJ</td><td align="left" rowspan="1" colspan="1">Conception and design study; realization of operations and/or trials;
manuscript writing or critical review of its content; final manuscript approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">VGL</td><td align="left" rowspan="1" colspan="1">Conception and design study; realization of operations and/ or
trials; analysis and/or data interpretation; final manuscript approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MAM</td><td align="left" rowspan="1" colspan="1">Conception and design study; manuscript writing or critical review of
its content; final manuscript approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">OMG</td><td align="left" rowspan="1" colspan="1">Conception and design study; manuscript writing or critical review of
its content; final manuscript approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MLL</td><td align="left" rowspan="1" colspan="1">Analysis and/or data interpretation; statistical analysis; final
manuscript approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ECVO</td><td align="left" rowspan="1" colspan="1">Analysis and/or data interpretation; statistical analysis; final
manuscript approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">EK</td><td align="left" rowspan="1" colspan="1">Analysis and/or data interpretation; manuscript writing or critical
review of its content; final manuscript approval</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn><fn fn-type="other"><p>This study was carried out at Hospital Aroldo Tourinho, Montes Claros, MG, Brazil.</p></fn><fn fn-type="supported-by"><p>No financial support.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>D</given-names></name><name><surname>Talajic</surname><given-names>M</given-names></name><name><surname>Dorian</surname><given-names>P</given-names></name><name><surname>Connolly</surname><given-names>S</given-names></name><name><surname>Eisenberg</surname><given-names>MJ</given-names></name><name><surname>Green</surname><given-names>M</given-names></name><etal/></person-group><article-title>Amiodarone to prevent recurrence of atrial fibrillation Canadian Trial of
Atrial Fibrillation Investigators</article-title><source>N Engl J Med</source><year>2000</year><volume>342</volume><issue>13</issue><fpage>913</fpage><lpage>920</lpage><pub-id pub-id-type="pmid">10738049</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wyse</surname><given-names>DG</given-names></name><name><surname>Waldo</surname><given-names>AL</given-names></name><name><surname>DiMarco</surname><given-names>JP</given-names></name><name><surname>Domanski</surname><given-names>MJ</given-names></name><name><surname>Rosenberg</surname><given-names>Y</given-names></name><name><surname>Schron</surname><given-names>EB</given-names></name><etal/><collab>Atrial Fibrillation Follow-up Investigation of Rhythm Management
Investigators</collab></person-group><article-title>A comparison of rate control and rhythm control in patients with atrial
fibrillation</article-title><source>N Engl J Med</source><year>2002</year><volume>347</volume><issue>23</issue><fpage>1825</fpage><lpage>1833</lpage><pub-id pub-id-type="pmid">12466506</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahangiri</surname><given-names>M</given-names></name><name><surname>Weir</surname><given-names>G</given-names></name><name><surname>Mandal</surname><given-names>K</given-names></name><name><surname>Savelieva</surname><given-names>I</given-names></name><name><surname>Camm</surname><given-names>J</given-names></name></person-group><article-title>Current strategies in the management of atrial fibrillation</article-title><source>Ann Thorac Surg</source><year>2006</year><volume>82</volume><issue>1</issue><fpage>357</fpage><lpage>364</lpage><pub-id pub-id-type="pmid">16798260</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haissaguerre</surname><given-names>M</given-names></name><name><surname>Jais</surname><given-names>P</given-names></name><name><surname>Shah</surname><given-names>DC</given-names></name><name><surname>Takahashi</surname><given-names>A</given-names></name><name><surname>Hocini</surname><given-names>M</given-names></name><name><surname>Quiniou</surname><given-names>G</given-names></name><etal/></person-group><article-title>Spontaneous initiation of atrial fibrillation by ectopic beats originating
in the pulmonary veins</article-title><source>N Engl J Med</source><year>1998</year><volume>339</volume><issue>10</issue><fpage>659</fpage><lpage>666</lpage><pub-id pub-id-type="pmid">9725923</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brick</surname><given-names>AV</given-names></name><name><surname>Seixas</surname><given-names>T</given-names></name><name><surname>Portilho</surname><given-names>C</given-names></name><name><surname>Peres</surname><given-names>AK</given-names></name><name><surname>Vieira</surname><given-names>JJ</given-names><suffix>Jr</suffix></name><name><surname>Melo</surname><given-names>R</given-names><suffix>Neto</suffix></name><etal/></person-group><article-title>Tratamento intra-operat&#x000f3;rio da fibrila&#x000e7;&#x000e3;o atrial
cr&#x000f4;nica com ultra-som</article-title><source>Rev Bras Cir Cardiovasc</source><year>2001</year><volume>16</volume><issue>4</issue><fpage>337</fpage><lpage>349</lpage></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalil</surname><given-names>RAK</given-names></name><name><surname>Lima</surname><given-names>GG</given-names></name><name><surname>Leiria</surname><given-names>TLL</given-names></name><name><surname>Abrah&#x000e3;o</surname><given-names>R</given-names></name><name><surname>Pires</surname><given-names>LM</given-names></name><name><surname>Prates</surname><given-names>PR</given-names></name><etal/></person-group><article-title>Simple surgical isolation of pulmonary veins for treating secondary atrial
fibrillation in mitral valve disease</article-title><source>Ann Thorac Surg</source><year>2002</year><volume>73</volume><issue>4</issue><fpage>1169</fpage><lpage>1173</lpage><pub-id pub-id-type="pmid">11996258</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coumel</surname><given-names>P</given-names></name><name><surname>Aigueperse</surname><given-names>J</given-names></name><name><surname>Perrault</surname><given-names>MA</given-names></name><name><surname>Fantoni</surname><given-names>A</given-names></name><name><surname>Scama</surname><given-names>R</given-names></name><name><surname>Bouvrain</surname><given-names>Y</given-names></name></person-group><article-title>Reperrage et tentative d' exerese chirurgicale d'un foyer ectopique
auriculaire gauche avec tachycardie rebelle evolution favorable</article-title><source>Ann Cardiol Angeiol</source><year>1973</year><volume>22</volume><issue>3</issue><fpage>189</fpage><lpage>199</lpage></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blomstrom-Lundqvist</surname><given-names>C</given-names></name><name><surname>Johansson</surname><given-names>B</given-names></name><name><surname>Berglin</surname><given-names>E</given-names></name><name><surname>Nilsson</surname><given-names>L</given-names></name><name><surname>Jensen</surname><given-names>SM</given-names></name><name><surname>Thelin</surname><given-names>S</given-names></name><etal/></person-group><article-title>A randomized double-blind study of epicardial left atrial cryoablation for
permanent atrial fibrillation in patients undergoing mitral valve surgery the SWEDish
Multicentre Atrial Fibrillation study (SWEDMAF)</article-title><source>Eur Heart J</source><year>2007</year><volume>28</volume><issue>23</issue><fpage>2902</fpage><lpage>2908</lpage><pub-id pub-id-type="pmid">17984136</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>OM</given-names></name><name><surname>Gomes</surname><given-names>ES</given-names></name></person-group><article-title>Nova abordagem t&#x000e9;cnica e eletrofisiol&#x000f3;gica para tratamento da
fibrila&#x000e7;&#x000e3;o atrial</article-title><source>Rev Bras Cir Cardiovasc</source><year>2004</year><volume>19</volume><issue>2</issue><fpage>120</fpage><lpage>125</lpage></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stulak</surname><given-names>JM</given-names></name><name><surname>Dearani</surname><given-names>JA</given-names></name><name><surname>Daly</surname><given-names>RC</given-names></name><name><surname>Zehr</surname><given-names>KJ</given-names></name><name><surname>Sundt 3rd</surname><given-names>TM</given-names></name><name><surname>Schaff</surname><given-names>HV</given-names></name></person-group><article-title>Left ventricular dysfunction in atrial fibrillation restoration of sinus
rhythm by the Cox-maze procedure significantly improves systolic function and functional
status</article-title><source>Ann Thorac Surg</source><year>2006</year><volume>82</volume><issue>2</issue><fpage>494</fpage><lpage>500</lpage><pub-id pub-id-type="pmid">16863752</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kannel</surname><given-names>WB</given-names></name></person-group><article-title>Epidemiology of cardiovascular disease in the elderly an assessment of risk
factors</article-title><source>Cardiovasc Clin</source><year>1992</year><volume>22</volume><issue>2</issue><fpage>9</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">1534033</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname><given-names>PM</given-names></name><name><surname>Kruse</surname><given-names>J</given-names></name><name><surname>Shalli</surname><given-names>S</given-names></name><name><surname>Ilkhanoff</surname><given-names>L</given-names></name><name><surname>Goldberger</surname><given-names>JJ</given-names></name><name><surname>Kadish</surname><given-names>AH</given-names></name><etal/></person-group><article-title>Where does atrial fibrillation surgery fail Implications for increasing
effectiveness of ablation</article-title><source>J Thorac Cardiovasc Surg</source><year>2010</year><volume>139</volume><issue>4</issue><fpage>860</fpage><lpage>867</lpage><pub-id pub-id-type="pmid">20304134</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jatene</surname><given-names>MB</given-names></name><name><surname>Barbero-Marcial</surname><given-names>M</given-names></name><name><surname>Tarasoutchi</surname><given-names>F</given-names></name><name><surname>Cardoso</surname><given-names>RA</given-names></name><name><surname>Pomerantzeff</surname><given-names>PMA</given-names></name><name><surname>Jatene</surname><given-names>AD</given-names></name></person-group><article-title>Influ&#x000ea;ncia da opera&#x000e7;&#x000e3;o de Cox no tratamento de
fibrila&#x000e7;&#x000e3;o atrial em valvopatia mitral reum&#x000e1;tica an&#x000e1;lise
comparativa de resultados imediatos e tardios</article-title><source>Rev Bras Cir Cardiovasc</source><year>1998</year><volume>13</volume><issue>2</issue><fpage>105</fpage><lpage>119</lpage></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jazbik</surname><given-names>JC</given-names></name><name><surname>Coutinho</surname><given-names>JH</given-names></name><name><surname>Amar</surname><given-names>MR</given-names></name><name><surname>Silva</surname><given-names>SL</given-names></name><name><surname>Jazbik</surname><given-names>J</given-names><suffix>Sobrinho</suffix></name><name><surname>Jazbik</surname><given-names>AT</given-names></name><etal/></person-group><article-title>Tratamento cir&#x000fa;rgico da fibrila&#x000e7;&#x000e3;o atrial em pacientes
com insufici&#x000ea;ncia mitral proposta inicial de uma nova abordagem
cir&#x000fa;rgica</article-title><source>Rev SOCERJ</source><year>1993</year><volume>6</volume><issue>3</issue><fpage>142</fpage><lpage>145</lpage></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasconcelos</surname><given-names>JTM</given-names></name><name><surname>Scanavacca</surname><given-names>MI</given-names></name><name><surname>Sampaio</surname><given-names>RO</given-names></name><name><surname>Grinberg</surname><given-names>M</given-names></name><name><surname>Sosa</surname><given-names>EA</given-names></name><name><surname>Oliveira</surname><given-names>SA</given-names></name></person-group><article-title>Tratamento cir&#x000fa;rgico da fibrila&#x000e7;&#x000e3;o atrial por
isolamento da parede posterior do &#x000e1;trio esquerdo em doentes com valvopatia mitral
reum&#x000e1;tica cr&#x000f4;nica um estudo randomizado com grupo controle</article-title><source>Arq Bras Cardiol</source><year>2004</year><volume>83</volume><issue>3</issue><fpage>203</fpage><lpage>210</lpage></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frame</surname><given-names>LH</given-names></name><name><surname>Page</surname><given-names>RL</given-names></name><name><surname>Boyden</surname><given-names>PA</given-names></name><name><surname>Fenoglio</surname><given-names>JJ</given-names><suffix>Jr</suffix></name><name><surname>Hoffman</surname><given-names>BF</given-names></name></person-group><article-title>Circus movement in the canine atrium around the tricuspid ring during
experimental atrial flutter and during reentry in vitro</article-title><source>Circulation</source><year>1987</year><volume>76</volume><issue>5</issue><fpage>1155</fpage><lpage>1175</lpage><pub-id pub-id-type="pmid">3665000</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>JL</given-names></name><name><surname>Boineau</surname><given-names>JP</given-names></name><name><surname>Schuessler</surname><given-names>RB</given-names></name><name><surname>Kater</surname><given-names>KM</given-names></name><name><surname>Lappas</surname><given-names>DG</given-names></name></person-group><article-title>Five-year experience with the maze procedure for atrial
fibrillation</article-title><source>Ann Thorac Surg</source><year>1993</year><volume>56</volume><issue>4</issue><fpage>814</fpage><lpage>823</lpage><pub-id pub-id-type="pmid">8215657</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>JF</given-names><suffix>J&#x000fa;nior</suffix></name><name><surname>Pontes</surname><given-names>JCDV</given-names></name><name><surname>Gomes</surname><given-names>OM</given-names></name><name><surname>Duarte</surname><given-names>JJ</given-names></name><name><surname>Gardenal</surname><given-names>N</given-names></name><name><surname>Dias</surname><given-names>AMAS</given-names></name><etal/></person-group><chapter-title>Tratamento cir&#x000fa;rgico da fibrila&#x000e7;&#x000e3;o atrial
cr&#x000f4;nica com eletrocaut&#x000e9;rio convencional em cirurgia valvar
mitral</chapter-title><source>Rev Bras Cir Cardiovasc.</source><year>2008</year><volume>23</volume><issue>3</issue><fpage>365</fpage><lpage>371</lpage><pub-id pub-id-type="pmid">19082325</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saad</surname><given-names>EB</given-names></name><name><surname>Camanho</surname><given-names>LE</given-names></name></person-group><article-title>Estado atual da abla&#x000e7;&#x000e3;o de fibrila&#x000e7;&#x000e3;o atrial
t&#x000e9;cnicas, pacientes e resultados</article-title><source>Relampa</source><year>2010</year><volume>23</volume><issue>4</issue><fpage>223</fpage><lpage>229</lpage></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kosakai</surname><given-names>Y</given-names></name><name><surname>Kawaguchi</surname><given-names>AT</given-names></name><name><surname>Isobe</surname><given-names>F</given-names></name><name><surname>Sasako</surname><given-names>Y</given-names></name><name><surname>Nakano</surname><given-names>K</given-names></name><name><surname>Eishi</surname><given-names>K</given-names></name><etal/></person-group><article-title>Modified maze procedure for patients with atrial fibrillation undergoing
simultaneous open heart surgery</article-title><source>Circulation</source><year>1995</year><volume>92</volume><issue>9 Suppl</issue><fpage>II359</fpage><lpage>II364</lpage><pub-id pub-id-type="pmid">7586438</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lins</surname><given-names>RMM</given-names></name><name><surname>Lima</surname><given-names>RC</given-names></name><name><surname>Silva</surname><given-names>FPV</given-names></name><name><surname>Menezes</surname><given-names>AM</given-names></name><name><surname>Salerno</surname><given-names>PR</given-names></name><name><surname>Th&#x000e9;</surname><given-names>EC</given-names></name><etal/></person-group><article-title>Tratamento da fibrila&#x000e7;&#x000e3;o atrial com abla&#x000e7;&#x000e3;o por
ultrassom, durante corre&#x000e7;&#x000e3;o cir&#x000fa;rgica de doen&#x000e7;a valvar
card&#x000ed;aca</article-title><source>Rev Bras Cir Cardiovasc</source><year>2010</year><volume>25</volume><issue>3</issue><fpage>326</fpage><lpage>332</lpage><pub-id pub-id-type="pmid">21103740</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calkins</surname><given-names>H</given-names></name><name><surname>Brugada</surname><given-names>J</given-names></name><name><surname>Packer</surname><given-names>DL</given-names></name><name><surname>Cappato</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>SA</given-names></name><name><surname>Crijns</surname><given-names>HJ</given-names></name><name><surname>Heart Rhythm</surname><given-names>S</given-names></name><etal/><collab>European Heart Rhythm A</collab><collab>European Cardiac Arrhythmia S</collab><collab>American College of C</collab><collab>American Heart A</collab><collab>Society of Thoracic S</collab></person-group><article-title>HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation
of atrial fibrillation recommendations for personnel, policy, procedures and follow-up.
A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation
of Atrial Fibrillation developed in partnership with the European Heart Rhythm
Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration
with the American College of Cardiology (ACC), American Heart Association (AHA), and the
Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the
American College of Cardiology, the American Heart Association, the European Cardiac
Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic
Surgeons, and the Heart Rhythm Society</article-title><source>Europace</source><year>2007</year><volume>9</volume><issue>6</issue><fpage>335</fpage><lpage>379</lpage><pub-id pub-id-type="pmid">17599941</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandoval</surname><given-names>N</given-names></name><name><surname>Velasco</surname><given-names>VM</given-names></name><name><surname>Orjuela</surname><given-names>H</given-names></name><name><surname>Caicedo</surname><given-names>V</given-names></name><name><surname>Santos</surname><given-names>H</given-names></name><name><surname>Rosas</surname><given-names>F</given-names></name><etal/></person-group><article-title>Concomitant mitral valve or atrial septal defect surgery and the modified
Cox-maze procedure</article-title><source>Am J Cardiol</source><year>1996</year><volume>77</volume><issue>8</issue><fpage>591</fpage><lpage>596</lpage><pub-id pub-id-type="pmid">8610608</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boersma</surname><given-names>LV</given-names></name><name><surname>Castella</surname><given-names>M</given-names></name><name><surname>van Boven</surname><given-names>W</given-names></name><name><surname>Berruezo</surname><given-names>A</given-names></name><name><surname>Yilmaz</surname><given-names>A</given-names></name><name><surname>Nadal</surname><given-names>M</given-names></name><etal/></person-group><article-title>Atrial fibrillation catheter ablation versus surgical ablation treatment
(FAST) a 2-center randomized clinical trial</article-title><source>Circulation</source><year>2012</year><volume>125</volume><issue>1</issue><fpage>23</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">22082673</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canale</surname><given-names>LS</given-names></name><name><surname>Colafranceschi</surname><given-names>AS</given-names></name><name><surname>Monteiro</surname><given-names>AJ</given-names></name><name><surname>Coimbra</surname><given-names>M</given-names></name><name><surname>Weksler</surname><given-names>C</given-names></name><name><surname>Koehler</surname><given-names>E</given-names></name><etal/></person-group><article-title>Uso da radiofrequ&#x000ea;ncia bipolar para o tratamento da
fibrila&#x000e7;&#x000e3;o atrial durante cirurgia card&#x000ed;aca</article-title><source>Arq Bras Cardiol</source><year>2001</year><volume>96</volume><issue>6</issue><fpage>457</fpage><lpage>464</lpage></element-citation></ref></ref-list></back></article>